16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management

16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management

[!NOTE] Blueprint anchor: Domain 8 (Psychosocial Management), task 8.9 — Educate on the relationship between psychosocial considerations and other health issues (e.g., GI, chronic pain, impaired immune response, sleep disturbances).

Depression, poor sleep, chronic pain, and gastrointestinal symptoms cluster together and reinforce one another. A patient who is not sleeping is more depressed; a patient in pain exercises less and sleeps worse; untreated sleep apnea drives resistant hypertension and atrial fibrillation. Treating any one of these in isolation frequently fails, which is why the blueprint asks you to understand the connections.

---

Obstructive Sleep Apnea

OSA is strikingly common in cardiovascular populations and is frequently undiagnosed.

Cardiovascular consequences

Repetitive apneas produce intermittent hypoxemia, large intrathoracic pressure swings, arousals, and sympathetic surges. The downstream associations include:

• Resistant hypertension and a non-dipping nocturnal blood pressure pattern
• Atrial fibrillation, with higher recurrence after cardioversion and ablation when OSA is untreated
• Heart failure — both HFrEF and HFpEF
• Stroke, pulmonary hypertension, and nocturnal arrhythmia
• Insulin resistance and worsened glycemic control

STOP-BANG screening

Score 0-2: low risk. 3-4: intermediate risk. 5-8: high risk. A score of 3 or higher warrants discussion and referral consideration; 5 or higher warrants referral for sleep evaluation. The Epworth Sleepiness Scale complements it by quantifying daytime sleepiness.

[!IMPORTANT] A CR patient with resistant hypertension, recurrent atrial fibrillation, or excessive daytime sleepiness should be screened for OSA. Identifying it is one of the highest-value referrals a CR program makes, because treatment can improve blood pressure control and arrhythmia recurrence. For patients already on CPAP, ask about adherence — nightly hours of use — because prescribed therapy that sits in a closet delivers nothing, and common barriers such as mask fit, pressure intolerance, and nasal dryness are all solvable when reported.

---

Insomnia

Insomnia and depression are bidirectional: each causes and worsens the other, and insomnia is a risk factor for the development and recurrence of depression. Both short sleep (under about 6 hours) and long sleep are associated with adverse cardiovascular outcomes.

[!IMPORTANT] Cognitive behavioral therapy for insomnia (CBT-I) is first-line treatment for chronic insomnia, recommended ahead of hypnotic medication. Its components — stimulus control, sleep restriction, cognitive restructuring, and sleep hygiene — produce durable benefit without the fall risk, cognitive impairment, and dependence associated with hypnotics and benzodiazepines in older cardiac patients.

Sleep hygiene counseling within CR scope: consistent sleep and wake times, a dark and cool bedroom, restricting the bed to sleep, limiting caffeine after midday and alcohol near bedtime (alcohol fragments sleep architecture despite hastening sleep onset), limiting screens before bed, and getting daytime light exposure. Regular exercise improves sleep quality, though some patients sleep worse when exercising vigorously close to bedtime and should shift sessions earlier.

Also consider that nocturnal dyspnea or orthopnea may represent heart failure rather than insomnia, that diuretic timing late in the day causes nocturia, and that nocturnal angina requires cardiac rather than sleep evaluation.

---

Chronic Pain

Chronic pain limits participation, worsens mood and sleep, and is frequently the reason a patient stops attending.

Analgesic cardiovascular safety

[!WARNING] NSAIDs — ibuprofen, naproxen, diclofenac, celecoxib — carry substantial cardiovascular liability:

• Raise blood pressure and antagonize antihypertensive efficacy
• Cause sodium and fluid retention, precipitating heart failure decompensation
• Increase cardiovascular events, with the risk elevated in patients with established coronary disease
• Reduce renal perfusion, harmful with chronic kidney disease and with RAAS blockade plus a diuretic
• Blunt aspirin's antiplatelet effect when ibuprofen is taken before aspirin; if both are used, aspirin should be taken first with an appropriate interval

Acetaminophen is generally the preferred first-line oral analgesic in cardiac patients, within hepatic dose limits.

Opioids bring sedation, constipation, fall risk, and limited long-term benefit for chronic non-cancer pain, and a sedated patient on a treadmill is a safety issue. Note the pain-relevant psychotropics that overlap with the previous section: duloxetine for neuropathic pain and low-dose amitriptyline for neuropathic pain or sleep, the latter carrying orthostatic, anticholinergic, and QT concerns in cardiac patients.

Behavioral approach

Pain catastrophizing and fear-avoidance beliefs predict disability better than pain intensity does. The effective CR strategy is graded activity and pacing: start well below the flare threshold, progress on a time-based rather than pain-based schedule, and explicitly separate hurt from harm, since musculoskeletal discomfort during graded activity does not indicate tissue damage. Choose low-impact modalities and consider aquatic options where available.

---

Gastrointestinal Overlap

• GERD mimics angina. Both produce substernal burning, both can radiate, and both may occur after meals. Never assume reflux in a patient with known coronary disease — evaluate as cardiac until proven otherwise, and note that relief with antacids does not exclude ischemia.
• Stress and anxiety drive functional GI symptoms, and the gut-brain relationship is bidirectional.

[!WARNING] PPI and clopidogrel interaction. Clopidogrel is a prodrug requiring CYP2C19 activation. Omeprazole and esomeprazole inhibit CYP2C19, reducing clopidogrel's antiplatelet effect. Pantoprazole is generally preferred when a proton pump inhibitor is needed alongside clopidogrel. This interaction does not apply to prasugrel or ticagrelor, which do not depend on CYP2C19 activation.

---

Impaired Immune Response and Inflammation

Chronic psychological stress and depression are associated with elevated inflammatory markers including C-reactive protein and interleukin-6, sympathetic and HPA-axis activation with cortisol dysregulation, impaired immune function and slower wound healing, and increased platelet reactivity. This inflammatory pathway is one of the principal proposed mechanisms linking depression to worse cardiovascular outcomes — depression is not merely a comorbid mood problem but a plausible biological contributor. Framing it this way for patients reduces stigma: treating depression is cardiac care.

---

Differentiating Fatigue

Fatigue is the common final pathway of nearly everything discussed here, and distinguishing causes changes management:

---

Realistic Clinical Scenario

Scenario: A 62-year-old man with atrial fibrillation recurring twice since ablation and blood pressure of 152/92 despite three antihypertensives reports profound daytime fatigue. He snores loudly, his wife has observed him stop breathing, his BMI is 37, neck circumference 44 cm, and he is 62 years old. His PHQ-9 is 11. He takes ibuprofen most days for knee osteoarthritis and omeprazole for reflux. He is on clopidogrel.

Analysis: His STOP-BANG score is 8 — snoring, tired, observed apnea, treated hypertension, BMI over 35, age over 50, neck over 40 cm, male — placing him at high risk for obstructive sleep apnea, which plausibly explains his resistant hypertension, his post-ablation atrial fibrillation recurrence, and his fatigue simultaneously. Two medication problems compound it: daily ibuprofen raises blood pressure, antagonizes his three antihypertensives, causes fluid retention, and adds cardiovascular risk; and omeprazole inhibits CYP2C19, reducing activation of his clopidogrel and blunting its antiplatelet effect. His PHQ-9 of 11 indicates moderate depressive symptoms that both contribute to and result from the poor sleep.

Plan: Refer for sleep evaluation as the highest-yield action — a STOP-BANG of 8 with resistant hypertension and recurrent atrial fibrillation makes untreated OSA the likely unifying diagnosis. Report both medication issues to the prescriber with specifics: recommend substituting acetaminophen for daily ibuprofen within hepatic limits and switching omeprazole to pantoprazole to preserve clopidogrel activation, while leaving the decisions to the prescriber. Address the knee pain with a graded, low-impact, time-based progression that separates hurt from harm rather than pain-limited activity. Deliver sleep hygiene counseling and schedule his sessions earlier in the day. Refer for behavioral health evaluation given the PHQ-9 of 11, framing depression treatment as cardiac care, and re-administer the PHQ-9 at the 30-day update.